The Association of C-Reactive Protein and CRP Genotype with Coronary Heart Disease: Findings from Five Studies with 4,610 Cases amongst 18,637 Participants

Background It is unclear whether C-reactive protein (CRP) is causally related to coronary heart disease (CHD). Genetic variants that are known to be associated with CRP levels can be used to provide causal inference of the effect of CRP on CHD. Our objective was to examine the association between CRP genetic variant +1444C>T (rs1130864) and CHD risk in the largest study to date of this association. Methods and Results We estimated the association of CRP genetic variant +1444C>T (rs1130864) with CRP levels and with CHD in five studies and then pooled these analyses (N = 18,637 participants amongst whom there were 4,610 cases). CRP was associated with potential confounding factors (socioeconomic position, physical activity, smoking and body mass) whereas genotype (rs1130864) was not associated with these confounders. The pooled odds ratio of CHD per doubling of circulating CRP level after adjustment for age and sex was 1.13 (95%CI: 1.06, 1.21), and after further adjustment for confounding factors it was 1.07 (95%CI: 1.02, 1.13). Genotype (rs1130864) was associated with circulating CRP; the pooled ratio of geometric means of CRP level among individuals with the TT genotype compared to those with the CT/CC genotype was 1.21 (95%CI: 1.15, 1.28) and the pooled ratio of geometric means of CRP level per additional T allele was 1.14 (95%CI: 1.11, 1.18), with no strong evidence in either analyses of between study heterogeneity (I2 = 0%, p>0.9 for both analyses). There was no association of genotype (rs1130864) with CHD: pooled odds ratio 1.01 (95%CI: 0.88, 1.16) comparing individuals with TT genotype to those with CT/CC genotype and 0.96 (95%CI: 0.90, 1.03) per additional T allele (I2<7.5%, p>0.6 for both meta-analyses). An instrumental variables analysis (in which the proportion of CRP levels explained by rs1130864 was related to CHD) suggested that circulating CRP was not associated with CHD: the odds ratio for a doubling of CRP level was 1.04 (95%CI: 0.61, 1.80). Conclusions We found no association of a genetic variant, which is known to be related to CRP levels, (rs1130864) and having CHD. These findings do not support a causal association between circulating CRP and CHD risk, but very large, extended, genetic association studies would be required to rule this out.

[1]  J. Danesh,et al.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.

[2]  D. Strachan,et al.  LDL-cholesterol concentrations: a genome-wide association study , 2008, The Lancet.

[3]  N. Cook,et al.  Association of Common CRP Gene Variants with CRP Levels and Cardiovascular Events , 2005, Annals of human genetics.

[4]  P. Elwood,et al.  Associations of the HDL2 and HDL3 Cholesterol Subfractions With the Development of Ischemic Heart Disease in British Men: The Caerphilly and Speedwell Collaborative Heart Disease Studies , 1994, Circulation.

[5]  E. Thompson,et al.  Performing the exact test of Hardy-Weinberg proportion for multiple alleles. , 1992, Biometrics.

[6]  George Davey Smith,et al.  Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.

[7]  D. Levy,et al.  Contribution of Clinical Correlates and 13 C-Reactive Protein Gene Polymorphisms to Interindividual Variability in Serum C-Reactive Protein Level , 2006, Circulation.

[8]  D. Lawlor,et al.  Clustered Environments and Randomized Genes: A Fundamental Distinction between Conventional and Genetic Epidemiology , 2007, PLoS medicine.

[9]  Juan P Casas,et al.  Insight into the nature of the CRP-coronary event association using Mendelian randomization. , 2006, International journal of epidemiology.

[10]  Tom R. Gaunt,et al.  C-reactive protein and its role in metabolic syndrome: mendelian randomisation study , 2005, The Lancet.

[11]  G. Lowe,et al.  C-reactive protein and cardiovascular disease: Weighing the evidence , 2006, Current atherosclerosis reports.

[12]  A. J. Bass,et al.  Population‐based linkage of health records in Western Australia: development of a health services research linked database , 1999, Australian and New Zealand journal of public health.

[13]  G. Smith.  Randomised by (your) god: robust inference from an observational study design , 2006, Journal of Epidemiology and Community Health.

[14]  CRP CHD Genetics Collaboration,et al.  Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation , 2008, European Journal of Epidemiology.

[15]  D. Lawlor,et al.  C-Reactive Protein and Cardiovascular Disease Risk: Still an Unknown Quantity? , 2006, Annals of Internal Medicine.

[16]  Jonathan C. Cohen,et al.  A Common Allele on Chromosome 9 Associated with Coronary Heart Disease , 2007, Science.

[17]  D. Lawlor,et al.  Lifecourse Socioeconomic Position, C-Reactive Protein, and Carotid Intima-Media Thickness in Young Adults: The Cardiovascular Risk in Young Finns Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[18]  P. Elliott,et al.  Common Variation in the FTO Gene Alters Diabetes-Related Metabolic Traits to the Extent Expected Given Its Effect on BMI , 2008, Diabetes.

[19]  P. Ridker,et al.  Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. , 2002, Atherosclerosis.

[20]  G. Lowe.  Circulating inflammatory markers and risks of cardiovascular and non‐cardiovascular disease , 2005, Journal of thrombosis and haemostasis : JTH.

[21]  S. Humphries,et al.  Human CRP Gene Polymorphism Influences CRP Levels: Implications for the Prediction and Pathogenesis of Coronary Heart Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Steven V. Ley,et al.  Targeting C-reactive protein for the treatment of cardiovascular disease , 2006, Nature.

[23]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[24]  N. Cook,et al.  Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. , 2005, Atherosclerosis.

[25]  Wolfgang Babisch,et al.  Traffic noise, work noise and cardiovascular risk factors : the Caerphilly and Speedwell collaborative heart disease studies , 1990 .

[26]  Jonathan C. Cohen,et al.  Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. , 2006, The New England journal of medicine.

[27]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[28]  H. Tunstall-Pedoe,et al.  Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.

[29]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[30]  M. Marmot,et al.  Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study , 2007, European Journal of Epidemiology.

[31]  Meena Kumari,et al.  Does High C-reactive Protein Concentration Increase Atherosclerosis? The Whitehall II Study , 2008, PloS one.

[32]  V. Salomaa,et al.  Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status , 2003, Journal of epidemiology and community health.

[33]  Jack Bowden,et al.  Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation , 2008 .

[34]  J. Goldstein,et al.  Lowering LDL--Not Only How Low, But How Long? , 2006, Science.

[35]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[36]  A. Hingorani,et al.  Nature's randomised trials , 2005, The Lancet.

[37]  P. Whincup,et al.  Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men , 2002, Circulation.

[38]  Debbie A Lawlor,et al.  Mendelian randomization suggests no causal association between C-reactive protein and carotid intima-media thickness in the young Finns study. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[39]  E. Rimm,et al.  C-Reactive Protein (CRP) Gene Polymorphisms, CRP Levels, and Risk of Incident Coronary Heart Disease in Two Nested Case-Control Studies , 2008, PloS one.

[40]  P. Whincup,et al.  Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. , 2005, European heart journal.

[41]  A. Szalai,et al.  C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. , 2007, Journal of the American College of Cardiology.

[42]  Shah Ebrahim,et al.  Association of C-Reactive Protein With Blood Pressure and Hypertension: Life Course Confounding and Mendelian Randomization Tests of Causality , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[43]  C. Carlson,et al.  Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. , 2005, American journal of human genetics.

[44]  N. Timpson,et al.  Letter by Timpson et al regarding article, "Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level". , 2006, Circulation.

[45]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.

[46]  S. Ebrahim,et al.  Mendelian randomization: prospects, potentials, and limitations. , 2004, International journal of epidemiology.

[47]  K. Jamrozik,et al.  Screening for abdominal aortic aneurysm: lessons from a population‐based study , 2000, The Medical journal of Australia.

[48]  L. Bautista.  Association of C-reactive protein with blood pressure. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[49]  R Peto,et al.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.

[50]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[51]  S. Humphries,et al.  C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. , 2005, Atherosclerosis.

[52]  L. Hansson,et al.  A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. , 2005, Atherosclerosis.

[53]  T M Hayes,et al.  Associations of alcohol consumption with plasma high density lipoprotein cholesterol and its major subfractions: the Caerphilly and Speedwell Collaborative Heart Disease Studies. , 1988, Journal of epidemiology and community health.

[54]  D. Allison,et al.  Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level , 2005, Journal of Molecular Medicine.

[55]  C. Carlson,et al.  Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. , 2006, JAMA.

[56]  D. Lawlor,et al.  The association of oestrogen receptor alpha-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study. , 2006, European heart journal.

[57]  D. Lawlor,et al.  Variants in the CRP gene as a measure of lifelong differences in average C-reactive protein levels: the Cardiovascular Risk in Young Finns Study, 1980-2001. , 2007, American journal of epidemiology.

[58]  Gower Street,et al.  Health inequalities among British civil servants: the Whitehall II study , 1991, The Lancet.

[59]  M. Rieder,et al.  Genetic Variation Is Associated With C-Reactive Protein Levels in the Third National Health and Nutrition Examination Survey , 2006, Circulation.

[60]  C. Gieger,et al.  Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.